Authors contributions

SL summarized the data, reviewed the literature, wrote this manuscript and included the remarks and corrections of the other authors.
EM contributed to the interpretation of the data, reviewed the literature and revised the manuscript.
HVN contributed to the interpretation of the data and revised the manuscript.
LODS contributed to the acquisition of data and their interpretation.
LML contributed to the acquisition of data and their interpretation.
PK contributed to the acquisition of data and their interpretation and revised the manuscript.
AG contributed to the acquisition of data and their interpretation.
PC contributed to the interpretation of the data, reviewed the literature and revised the manuscript.
References
  1. Zhao Q, Meng M, Kumar R,et al. Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis. Int J Infect Dis. 2020 May 4;96:131-135. doi: 10.1016/j.ijid.2020.04.086. Online ahead of print.
  2. He R, Lu Z, Zhang L, Fan T, et al. The clinical course and its correlated immune status in COVID-19 pneumonia. J Clin Virol. 2020 Apr 12;127:104361. doi: 10.1016/j.jcv.2020.104361. Online ahead of print.
  3. Fan BE, Chong VCL, Chan SSW, et al. Hematologic parameters in patients with COVID-19 infection. Am J Hematol 2020; 95: E131-E153 DOI: 10.1002/ajh.25774
  4. Yao Z, Zheng Z, Wu K,et al. Immune environment modulation in pneumonia patients caused by coronavirus: SARS-CoV, MERS-CoV and SARS-CoV-2. Aging (Albany NY). 2020; 12:7639-7651. https://doi.org/10.18632/aging.103101
  5. Liu J, Li S, Liu J, Liang B, et al. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. Version 2. E Bio Medicine 2020; 55: 102763. doi: 10.1016/j.ebiom.2020.102763
  6. Rutsaert L, Steinfort N, Van Hunsel T, et al. COVID‑19‑associated invasive pulmonary aspergillosis. Ann Intensive Care. 2020 Jun 1;10(1):71 https://doi.org/10.1186/s13613-020-00686-4
  7. Alanio A, Dellière S, Fodil S, et al. High Prevalence of Putative Invasive Pulmonary Aspergillosis in Critically Ill COVID-19 Patients (April 14, 2020), forthcoming. doi.org/10.2139/ssrn.3575581
  8. Koehler P, Cornely OA, Böttiger BW, et al. COVID-19 Associated Pulmonary Aspergillosis. Mycosis 2020 Jun;63(6):528-534 doi.org/10.1111/MYC.13096
  9. van Arkel ALE, Rijpstra TA, Belderbos HNA, et al. COVID-19 Associated Pulmonary Aspergillosis. Am J Respir Crit Care Med. 2020 Jul 1;202(1):132-135 doi: 10.1164/rccm.202004-1038LE
  10. Koulenti D, Garnacho-Montero J, Blot S. Approach to invasive pulmonary aspergillosis in critically ill patients. Curr Opin Infect Dis 2014; 27: 174-83
  11. D’Ardes D, Boccatona A, Schiavone C, et al. A Case of Coinfection with SARS-CoV-2 and Cytomegalovirus in the Era of COVID-19. EJCRIM 2020;7: doi:10.12890/2020_001652
  12. Lansbury L, Lim B, Baskaran V, et al. Co-infections in people with COVID-19: a systematic review and meta-analysis, Journal of Infection 2020 May 27;S0163-4453(20)30323-6. https://doi.org/10.1016/j.jinf.2020.05.046
  13. Bernard S, Germi R, Lupo J, et al. Symptomatic cytomegalovirus gastrointestinal infection with positive quantitative real-time PCR findings in apparently immunocompetent patients: a case series. Clin Microbiol Infect. 2015;21(12):1121.e1.
  14. Li X, Huang Y, Xu Z, et al. Cytomegalovirus infection and outcome in immunocompetent patients in the intensive care unit: a systematic review and meta-analysis. BMC Infect Dis. 2018 Jun 28;18(1):289. doi: 10.1186/s12879-018-3195-5.
  15. Heininger A, Jahn G, Engel C, et al. Human cytomegalovirus infections in nonimmunosuppressed critically ill patients. Crit Care Med. 2001;29(3):541–547. doi: 10.1097/00003246-200103000-00012.
  16. Sylwester AW, Mitchell BL, Edgar JB, et al. Broadly Targeted Human Cytomegalovirus-Specific CD4+ and CD8+ T Cells Dominate the Memory Compartments of Exposed Subjects. J Exp Med 2005;202(5):673-85. doi: 10.1084/jem.20050882.
  17. Giamarellos-Bourboulis EJ, Netea MG, Rovina N, et al. Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure. Cell Host & Microbe 2020; 27: 1-9 doi: 10.1016/j.chom.2020.04.009
  18. Roncati L, Nasillo V, Lusenti B, et al. Signals of Th2 immune response from COVID-19 patients requiring intensive care. Ann Hematol 2020 Jun;99(6):1419-1420 doi: 10.1007/s00277-020-04066-7
  19. Moss P. “The ancient and the new”: is there an interaction between cytomegalovirus and SARS-CoV-2 infection? Immun Ageing. 2020; 17: 14. doi: 10.1186/s12979-020-00185-x